GoldenGolden
Gatehouse Bio

Gatehouse Bio

A bio-data company that uses AI to analyze RNA sequencing data

Gatehouse Bio is a bio-data company in collaboration with AstraZeneca for the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s AI-powered platform. The sRNAlytics platform identifies small RNA (sRNA) signatures in sequencing data and points to molecular pathways that correlate to or potentially drive disease.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Gatehouse Bio Seed round, December 2020
December 2020
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

David W. Salzman

Founder, CEO

Neal Foster

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.